COURSE DIRECTOR
Philip W. Tipton, M.D.
DESCRIPTION
The Behavioral Neurology lecture series is designed to present fundamental knowledge and cutting edge clinical, pathological, genetics, neuroimaging, neuropsychological research, with evidence based information on neurodegenerative dementias for general neurologists, neurology subspecialists, psychiatrists, psychologists, geriatricians, internists, physicians in training, research scientists and graduate students, and other allied health staff. Experts from MCF, MCR, and MCA will be presenting in this weekly series.
TARGET AUDIENCE
This course is intended for Multidisciplinary (Physicians, mid-level health care providers, graduate students, clinical and research fellows).
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Describe the diagnostic process of mild and major neurocognitive impairment, Alzheimer’s disease (AD) and related disorders, and mild traumatic brain injury including the application of state-of-the-art research in biomarkers and neuroimaging techniques.
- Recognize the complex phenotypes of AD and related disorders as well as their pathological correlations.
- Describe the molecular pathophysiology of AD and related disorders.
- Apply the most updated and evidence-based knowledge on medications, psychological intervention, and alternative therapies for behavioral management in patients with cognitive impairment.
- Recognize different disease-modifying experimental pharmacological approaches targeting the pathophysiology of AD, and the effect of non-pharmacological interventions, such as diet and exercise, on AD risk reduction.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
Philip W. Tipton, M.D. - Honoraria - AbbVie Inc.; Intellectual Property - JOGO Health, Inc. (Coordinator)
All relevant financial relationships listed for these individuals have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Richard T. Bernard
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
CE Broker Code: 24R00680
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
QUESTIONS
Contact Richard Bernard